| Top 50 Most Viewed Posts This Month |
|---|
|
Today This Week Last Week This Month Last Month
|
1. Ganesha: Re: Current EIND policy at CYDY I wanted to let (1489)  (40) |
| 2. MJS719: Thank you brentie for the reminder of how (1472) (10) |
| 3. MGK_2: Patient A, is a 78-year-old female with a (1465) (15) |
| 4. Cycl2R: I don’t believe it has been noted here that the (1455) (12) |
| 5. My69z: Key to many LL approvals: Lung, Breast, Prostate, (1389) (2) |
| 6. dfwl28: Cytodyn Shareholders Community Michael Fumelle · (1231) (9) |
| 7. twinter11: Exceptionally broad HIV-1 neutralization via (1212) (9) |
| 8. Rosner: Short Interest Report As of Sat, Aug 3, '13 (1175) |
| 9. ohm20: If you add an ICI at this point to the phase 2 (874) (37) |
| 10. ohm20: This is exactly why they’re doing it. It's (860) (25) |
| 11. KenChowder: At the risk of being accused of cruelty to dead (846) (21) |
| 12. My69z: 3 yrs ago -- ICI Agreement with major institution (806) (8) |
| 13. Katangolo: Excellent observation! Didn’t work the first (745) (6) |
| 14. ohm20: Interesting interview with Dr. Patrick (695) (20) |
| 15. Enjay: I am posting this because of the ongoing (679) (9) |
| 16. brentie: CytoDyn's Strategic Positioning in Biopharma: A (674) (22) |
| 17. ohm20: The new research, though, highlights much smaller (649) (17) |
| 18. Nt2innvovate: Is it fair to say that the breath of leronmimab (640) (4) |
| 19. Emmitt: My baseball hypothesis: We’re in the playoffs. (636) (12) |
| 20. Crujones1985: I kind of think Dr Jay got a lot accomplished (629) (25) |
| 21. Evil Rabbit: We should see a PR about this in the next week or (619) (16) |
| 22. mountaineer: Quick Summary of 10Q (no surprises that I can (602) (15) |
| 23. Alberdo: For the trip, I used Otello and made a (602) |
| 24. gestalt2: Sorry if this has been discussed before, but is (598) (8) |
| 25. hoops: Very interesting theory. Buying time after (598) (3) |
| 26. My69z: Dressed for success: Aug 20th video ".....got (592) (11) |
| 27. MGK_2: To ohm or to anyone who might know, In the case (566) (6) |
| 28. CaptnAmerca: CFO Robert E. Hoffman to deliver company (565) (16) |
| 29. biloxiblues: This is a good read for the morning (564) (6) |
| 30. Niele: Thanks for the link to the article, Brentie. (558) (5) |
| 31. Evil Rabbit: I have a very close family member suffering with (551) (17) |
| 32. HouseofCards: Biloxi, I believe you said you were a stockbroker (547) (10) |
| 33. Evil Rabbit: It’s not about hedge funds, it's about new (545) (6) |
| 34. dfwl28: More on Hot and Cold Tumors: Excerpt: “Our (544) (6) |
| 35. jrt03: What I believe Dr. Dalton is trying to say from (541) (11) |
| 36. mikeyt1818: I am hoping that for once, Doc telling us we are (540) (7) |
| 37. ohm20: 1. Would a much, much larger basket trial (using (538) (19) |
| 38. MGK_2: So, in the experiment, they took 4 monkeys (536) (14) |
| 39. mightycydy: The current Leronlimab indication pipeline can be (532) (8) |
| 40. mountaineer: Something is horribly off today! I bought "the (526) (9) |
| 41. twinter11: If the incessant complaining on a shareholder (526) (11) |
| 42. My69z: Sept Letter & PoC Protocol: Based on the positive (522) (9) |
| 43. Buddyboy20: "My construcive suggestions: 1. Thank Stephen (522) (21) |
| 44. SamaGong: Ken, Are you too concerned about your press (519) (20) |
| 45. HHIGambler: "There appears to be gobs of safety data to (516) (7) |
| 46. Figgs: I feel the silence over the Summer and the (516) (4) |
| 47. chazzledazzle: Before I re-underline the Science Supplement from (515) (18) |
| 48. ohm20: With only 19,000 potential patients worldwide (513) (20) |
| 49. dfwl28: Nobel Prize for work in immunology/T cells (510) (1) |
| 50. Respert24: Nothing would please me more than being asked to (508) (19) |
